[Música] [Música] Muy buenas tardes. Quiero empezar con una pregunta. ¿Quiénes en este auditorio son empresarios.No se ve muy bien, pero bueno, veo bastantes manos levantadas. ¿Quiénes tienen ideas de negocio. y quieren crear empresa.Bueno, también ¿cómo se imaginarían su empresa si supieran que desde el primer día va a competir en un mercado global. ¿Lo harían vendiendo local o lo harían atreviéndose a vender internacional. Pues bien, quiero compartir con ustedes algunos datos importantes de qué tan global ...

I was born in a farmer's family in rural Spain. Yes, these hands had become garlic in the hot summer, grapes in the fall and in the cold winter. My grandparents were born during the civil war in Spain and then how my parents were uh grown up during a dictatorship in Spain.From my four grandparents, only one of my grandmother could properly read and write and do basic arithmetic operations. My two grandfathers could barely read and write and my other grandmother was fully illerate. My my parents were grown u ...

Google announces latest AI American Infrastructure Acadmey cohort | TechCrunch https://t.co/kMEFcn4qYH ...

The Prompt: OpenAI Backs New AI Training Academy For Teachers https://t.co/HbLbnef1wY https://t.co/HbLbnef1wY ...

Industry Focus - Jiangsu's party cadres are finding success with a bizarre idea [1]

Struggling with the long days and want to get your sleep schedule back on track? Then let in some early morning light. Bloomberg Prognosis explains how to ease circadian rhythm confusion. https://t.co/MTGu82bnGq ...

I want to take you back for just one moment to late 2022, early 2023. For me, it was the beginning of my freshman year in high school. And kind of overnight, it seemed like a new presence had kind of materialized onto my campus and every campus around the world.But it wasn't just campuses. It was every single news headline, every newsroom, every article seemed to be talking about one thing. Chad GBT.With the discussion of Chad GBT, it became immediate of all the things that it could possibly do. The way it ...

[Alkış] [Müzik] Merhaba, ben Burcu Kanin. Denizli'de fırıncı bir baba ve öğretmen bir annenin ilk evladı olarak dünyaya geldim. Burada anlatacağım hikayem sadece bir yaşam öyküsü değil. mücadeleyle, inançla ve dönüşümle örülmüş bir ruh yolculuğu. Doğduğun coğrafya kaderindir derler ya. Ben pek buna katılmasam da çocukluğunun geçirdiğin topraklarda ailenden gelen o görünmez e köklerin işte onlar ruhunun haritasını çizer. Benim ruhumun haritası rahmetli dedem ve anneannemin Kerpiç evinde çizildi. Ama asıl keş ...

SurveyForge团队 投稿 量子位 | 公众号 QbitAI 学术综述论文在科学研究中发挥着至关重要的作用，特别是在研究文献快速增长的时代。传统的人工驱动综述写作需要研究者审阅大量文章， 既耗时又难以跟上最新进展。而现有的自动化综述生成方法面临诸多挑战： AI生成的 综述结构 往往缺乏连贯逻辑，组织结构较差，存在宽度和深度的结构失衡问题；在 参考文献 方面，经常无法引用真正相关和有影 响力的文献，容易引用无关文献而忽略核心贡献； 评估方式 主要依赖LLM整体质量评估，缺乏对大纲质量、参考文献相关性等关键方面的细 粒度分析。 在此背景下，上海人工智能实验室联合复旦大学、上海交通大学等多家单位，提出了SurveyForge——一个自动化生成高质量学术综述论文的 创新框架，该研究已被ACL 2025主会议接收。 实验结果显示，SurveyForge在所有关键指标上都实现了显著提升：核心参考文献覆盖率提升了近一倍，大纲质量接近人工撰写水平，内容质 量在多个维度均超越现有方法。 更重要的是，系统生成约64k token的综述仅需不到$0.50（折合3.6元）的成本，整个过程在10分钟内完成。 | Methods ...

Summary of Becton, Dickinson and Company (BDX) FY Conference Call Company Overview - **Company**: Becton, Dickinson and Company (BDX) - **Date of Conference**: June 09, 2025 Key Points Industry and Market Dynamics - **Separation Process**: The company is in the process of separating its biosciences or life sciences segment, with an announcement expected between Labor Day and Memorial Day [2][3][4] - **Market Complexity**: BDX operates in a complex medtech portfolio, being the only medtech company with exposure to both life sciences and pharma device markets [31] - **Revenue Growth**: BDX has experienced a 5.6% revenue CAGR since launching BD 2025 in 2021, with current guidance for this year at 3.25% [32] Financial Performance - **Headwinds**: The company faces headwinds from a slowdown in research spending, destocking in the pharma medical device channel, and challenges in the Chinese market, which collectively have impacted growth by approximately 180 basis points [33][34] - **China Exposure**: Currently, 5% to 6% of revenue comes from China, expected to decrease to about 4% post-separation [35] - **Profitability**: Despite challenges, BDX has managed to expand gross margins by 190 basis points last quarter, achieving 8% EPS growth [92] Strategic Focus - **Shareholder Value**: The company is focused on maximizing shareholder value through potential separation options, including spin-offs or sales [6][14] - **Use of Proceeds**: Any proceeds from a sale will likely be used for stock buybacks, as the company views this as a strong investment opportunity at current price levels [22][23] - **Innovation Pipeline**: BDX has a robust innovation pipeline, with significant product launches planned for 2026, including advancements in biologic drug delivery and new medical devices [72][94] Challenges and Outlook - **Macro Challenges**: The company is navigating macroeconomic challenges, particularly in China and life sciences spending, but remains optimistic about revenue growth and operational performance [91] - **Future Growth**: Long-term growth expectations remain positive, with a projected return to high single-digit growth in the biologics space as the destocking phase concludes [73] Additional Insights - **Tariff Impact**: BDX anticipates $90 million in tariff exposure for FY 2025, primarily affecting Q4, but expects a net positive impact for FY 2026 due to recent tariff reductions [81][82] - **Legislative Considerations**: The company is closely monitoring legislative changes that could impact funding for healthcare providers and the medtech industry [85][86] Conclusion Becton, Dickinson and Company is strategically positioned to navigate current market challenges while focusing on innovation and shareholder value. The upcoming separation of its life sciences segment and a strong pipeline of new products are expected to drive future growth.